PIK3CD and acute myeloid leukemia: Indeed, the immune and leukocyte-restricted p110delta subunit of phosphatidylinositol-3-kinase (PI3K) [42], whose gene is PIK3CD, plays an important role in cell proliferation and has been proposed as a potential target in the treatment of AML [43, 44].